Dynamic changes in lncRNA expression were associated with the occurrence and progression of NAFLD, among which lncRNA NEAT1, MEG3, and MALAT1 exhibited great potential as biomarkers for NAFLD. The gene discussed is NEAT1; the disease is metabolic dysfunction-associated steatotic liver disease.